Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].

Veerus P, Hovi SL, Fischer K, Rahu M, Hakama M, Hemminki E.

Maturitas. 2006 Sep 20;55(2):162-73. Epub 2006 Feb 28.

PMID:
16504428
2.

Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757].

Vorobjov S, Hovi SL, Veerus P, Pisarev H, Rahu M, Hemminki E.

Maturitas. 2005 Nov-Dec;52(3-4):286-95. Epub 2005 Aug 1.

PMID:
16055284
3.

Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial.

Veerus P, Fischer K, Hakama M, Hemminki E; EPHT Trial.

BMC Med Res Methodol. 2012 Apr 4;12:44. doi: 10.1186/1471-2288-12-44.

4.

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

Ann Intern Med. 2000 May 2;132(9):689-96.

PMID:
10787361
5.

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV; Women's Health Initiative Investigators.

Diabetologia. 2004 Jul;47(7):1175-87. Epub 2004 Jul 14.

PMID:
15252707
6.

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.

Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR; Women's Health Initiative Investigators.

Obstet Gynecol. 2005 May;105(5 Pt 1):1063-73.

PMID:
15863546
7.

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R; Women's Health Initiative Investigators.

Arch Intern Med. 2006 Feb 13;166(3):357-65. Erratum in: Arch Intern Med. 2006 Apr 10;166(7):759.

PMID:
16476878
8.

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

Maturitas. 2006 Sep 20;55(2):103-15. Epub 2006 Jul 11.

PMID:
16815651
9.

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group.

BMJ. 2007 Aug 4;335(7613):239. Epub 2007 Jul 11.

10.

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

Herrington DM, Reboussin DM, Klein KP, Sharp PC, Shumaker SA, Snyder TE, Geisinger KR.

Control Clin Trials. 2000 Jun;21(3):257-85. Erratum in: Control Clin Trials 2000 Aug;21(4):414.

PMID:
10822123
11.

Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.

Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL.

Obstet Gynecol. 2006 Aug;108(2):410-9.

PMID:
16880313
12.

Predictors of heart failure among women with coronary disease.

Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG.

Circulation. 2004 Sep 14;110(11):1424-30. Epub 2004 Sep 7.

13.

Impact of cyclooxygenase inhibitors in the Women's Health Initiative hormone trials: secondary analysis of a randomized trial.

Hsia J, Manson JE, Kuller L, Pettinger M, Choe JH, Langer RD, Limacher M, Oberman A, Ockene J, O'Sullivan MJ, Robinson JG; Women's Health Initiative Research.

PLoS Clin Trials. 2006 Sep 29;1(5):e26.

14.

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.

Grodstein F, Manson JE, Stampfer MJ.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44.

PMID:
16417416
15.

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.

Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA; Women's Health Initiative Investigators.

Lancet. 2009 Oct 10;374(9697):1243-51. doi: 10.1016/S0140-6736(09)61526-9. Epub 2009 Sep 18.

16.

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.

Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J; WHI Investigators.

Circulation. 2006 May 23;113(20):2425-34. Epub 2006 May 15.

17.

Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.

Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM; Women's Health Initiative Investigators.

Circulation. 2004 Feb 10;109(5):620-6.

18.

Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative.

Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL.

Am J Clin Nutr. 2005 Sep;82(3):651-6.

19.

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Toh S, Hernández-Díaz S, Logan R, Rossouw JE, Hernán MA.

Ann Intern Med. 2010 Feb 16;152(4):211-7. doi: 10.7326/0003-4819-152-4-201002160-00005.

20.

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J; Women's Health Initiative Investigators.

Am J Epidemiol. 2005 Sep 1;162(5):404-14. Epub 2005 Jul 20.

Items per page

Supplemental Content

Write to the Help Desk